BioMarin to Participate in Three Upcoming Virtual Investor Conferences

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) announced participation in three virtual investor conferences on August 25, 2021. Live audio webcasts will be accessible on the company's investor relations page. Archived presentations will also be available for a limited period. BioMarin specializes in therapies for serious rare disorders, with six commercial products and various clinical candidates in its portfolio. For more details, visit www.biomarin.com.

SAN RAFAEL, Calif., Aug. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-upcoming-virtual-investor-conferences-301362189.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What events will BioMarin participate in August 2021?

BioMarin will participate in three virtual investor conferences.

Where can I access BioMarin's conference webcasts?

The webcasts will be available on BioMarin's investor relations page at www.biomarin.com.

What is BioMarin's focus in biotechnology?

BioMarin focuses on developing therapies for serious and life-threatening rare disorders.

How many commercial products does BioMarin have?

BioMarin has six commercialized products.

When was the press release about BioMarin's conferences issued?

The press release was issued on August 25, 2021.